1.
Characteristics | All (n=82) | After treatment (n=44) | P |
Gender | 0.899 | ||
Male | 55 | 30 | |
Female | 27 | 14 | |
Age (yrs) | 0.601 | ||
Median | 55 | 56 | |
Range | 29-80 | 29-74 | |
Non-small cell lung cancer | 0.588 | ||
Adenocarcinoma | 41 | 19 | |
Squamous | 20 | 7 | |
Performance status (ECOG) | 0.080 | ||
0 | 7 | 5 | |
1 | 37 | 19 | |
2 | 9 | 2 | |
3 | 6 | 0 | |
4 | 2 | 0 | |
Stage | 0.496 | ||
Ⅲa | 3 | 1 | |
Ⅲb | 20 | 12 | |
Ⅳ | 38 | 13 | |
Small cell lung cancer | 21 | 18 | |
Stage | 0.921 | ||
Limited disease | 9 | 8 | |
Extensive disease | 12 | 10 | |
Performance status (ECOG) | 0.600 | ||
0 | 2 | 2 | |
1 | 11 | 11 | |
2 | 6 | 5 | |
3 | 2 | 0 |